Healthcare Technologies (Israel) gets German approval for chlamydia test:
This article was originally published in Clinica
Healthcare Technologies (Israel) has received German marketing approval for its SeroELISA chlamydia kits. The assays, manufactured by subsidiary Savyon Diagnostics, are already approved in the US and Japan - where sales have reached ¥50 million pa ($1.8 million). The German industry association (VDGH) says the local chlamydia testing market is worth DM 14 million ($10 million) a year.